Ken Griffin’s Chardan Healthcare Acquisition 2 Corp. Units, each consisting of one share of Common Stock, and one CHAQ.U Stock Holding History

Ken Griffin’s Portfolio CHAQ.U Stock Details CHAQ.U Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-301,231	Closed	-$3.27M	–	15263
2021 Q2	$3.27M	Buy	301,231 +600	+0.2%	+$6.34K	﹤0.01%	5393
2021 Q1	$3.31M	Sell	300,631 -2,049	-0.7%	-$23.3K	﹤0.01%	5206
2020 Q4	$3.21M	Buy	302,680 +10	+0%	+$105	﹤0.01%	4487
2020 Q3	$3.19M	Sell	302,670 -399	-0.1%	-$4.16K	﹤0.01%	3879
2020 Q2	$3.18M	Buy	+303,069	New	+$3.04M	﹤0.01%	3755

Ken Griffin's CHAQ.U Position: Q3 2021 in Review

Ken Griffin sold out of Chardan Healthcare Acquisition 2 Corp. Units, each consisting of one share of Common Stock, and one (CHAQ.U) in Q3 2021, closing a stake of 301,231 shares — an estimated $3.27M sold.

Ken Griffin first reported a position in CHAQ.U in Q2 2020 and held it in 5 quarters. The position peaked at $3.31M in Q1 2021. 0 funds tracked by Wall St. Rank hold CHAQ.U as of Q3 2021.

Ken Griffin reported no remaining Chardan Healthcare Acquisition 2 Corp. Units, each consisting of one share of Common Stock, and one position as of Q3 2021 after selling out during the quarter.
Ken Griffin sold 301,231 Chardan Healthcare Acquisition 2 Corp. Units, each consisting of one share of Common Stock, and one shares in Q3 2021, an estimated $3.27M.
Ken Griffin first reported a position in Chardan Healthcare Acquisition 2 Corp. Units, each consisting of one share of Common Stock, and one in Q2 2020 and held it in 5 quarters.
Ken Griffin's Chardan Healthcare Acquisition 2 Corp. Units, each consisting of one share of Common Stock, and one position peaked at $3.31M in Q1 2021.
0 funds tracked by Wall St. Rank held Chardan Healthcare Acquisition 2 Corp. Units, each consisting of one share of Common Stock, and one as of Q3 2021.

Based on Citadel Advisors's 13F filing for Q3 2021, filed 15 Nov 2021.